Top 45 Medical Device Startup Investors in Denmark (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
BioInnovation Institute
VC Fund
|
10 | Denmark, Germany, Switzerland | Convertible Note, Pre-Seed, Debt Financing | Biotechnology, Medical, Health Care | $500k–$5.2M |
|
Export and Investment Fund
VC Fund
|
8 | Denmark, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Health Care | $457k–$43M |
|
PSV
VC Fund
|
8 | Denmark, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $88k–$4.7M |
|
Seed Capital
VC Fund
|
7 | Denmark, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $515k–$17M |
|
Vaekstfonden
VC Fund
|
7 | Denmark, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $412k–$4.6M |
|
People Ventures
VC Fund
|
4 | Denmark, Sweden, United States | Seed, Pre-Seed, Series A | Software, Health Care, Internet of Things | $1.1M–$21M |
|
Novo Holdings
VC Fund
|
4 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9M–$135M |
|
West Hill Capital
VC Fund
|
3 | United Kingdom, Denmark, Germany | Series A, Seed | Software, Health Care, Financial Services | $2M–$15M |
|
Chr. Augustinus Fabrikker
VC Fund
|
3 | Denmark | Series A, Series B, Series C | Software, Health Care, Medical Device | $16M–$82M |
|
VF Venture
VC Fund
|
3 | Denmark, United Kingdom, Iceland | Seed, Series A | Software, SaaS, Biotechnology | $1.2M–$22M |
|
Ugly Duckling Ventures
VC Fund
|
3 | Denmark, Sweden, Finland | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $876k–$7.5M |
|
Stine Molgaard Sorensen
Angel
|
2 | Denmark | Pre-Seed, Seed | Robotics, Software, Health Care | $174k–$1.5M |
|
NOON Ventures
VC Fund
|
2 | Denmark | Seed, Series A | Biotechnology, AgTech, Farming | $4.3M–$8.8M |
|
Innovation Fund Denmark
VC Fund
|
2 | Denmark, United States | Grant, Pre-Seed, Seed | Software, Biotechnology, SaaS | $29k–$1.6M |
|
Crista Galli Ventures
VC Fund
|
2 | United Kingdom, United States, Sweden | Seed, Pre-Seed, Series A | Health Care, Medical, Wellness | $655k–$14M |
|
Delphinus Venture Capital
VC Fund
|
2 | Denmark | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Food and Beverage, Wellness | $1.7M–$8.1M |
|
Alumni Ventures
VC Fund
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$79M |
|
Investo Capital
VC Fund
|
1 | Denmark | Seed | Medical Device, Health Diagnostics, mHealth | $1.6M–$3.4M |
|
Antler
VC Fund
|
1 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $108k–$28M |
|
GoBeyond
VC Fund
|
1 | Switzerland, Germany, United Kingdom | Seed, Series A | Information Technology, Medical, Software | $544k–$10M |
|
Roland Berger
Angel
|
1 | Germany, Denmark, Switzerland | Series A, Series B | Financial Services, Information Services, Apps | $4.9M–$30M |
|
Den Midtjyske Inværksätterfond
VC Fund
|
1 | Denmark | Seed | Medical, Health Care, Biotechnology | |
|
Steen Thygesen
Angel
|
1 | Denmark | Debt Financing | Medical Device, Product Design | |
|
Sunstone Life Science Ventures
VC Fund
|
1 | Denmark, Sweden, Switzerland | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$52M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $573k–$21M |
|
Sagitta Family Office
VC Fund
|
1 | Denmark | Series A | Biopharma, Health Care, Biotechnology | |
|
Penny Schiffer
Angel
|
1 | Switzerland, Germany, United Kingdom | Seed, Series A | Medical, Health Care, Finance | $544k–$9.3M |
|
Lauxera Capital Partners
VC Fund
|
1 | France, Sweden, China | Series A, Series C | Medical Device, Health Care, Biotechnology | $20M–$55M |
|
Digital Leaders Ventures
VC Fund
|
1 | United States, Denmark, France | Seed, Angel, Series A | SaaS, Mobile, Internet | $800k–$3M |
|
Seventure Partners
VC Fund
|
1 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.1M–$65M |
|
KMD Venture
VC Fund
|
1 | Denmark | Seed, Venture - Series Unknown | Information Technology, Education, Health Care | |
|
Swisscanto Private Equity
VC Fund
|
1 | Switzerland, Germany, Belgium | Series B, Series C | Health Care, Manufacturing, Robotics | |
|
Sagitta Ventures
VC Fund
|
1 | Denmark, United States, Sweden | Seed, Series A, Series B | Apps, Health Care, Mobile | $11M–$19M |
|
Verve Ventures
VC Fund
|
1 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | |
|
ATP
VC Fund
|
1 | Denmark | Series B | Health Care, Health Diagnostics, Software | |
|
Innovestor
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Pre-Seed | Software, Health Care, Information Technology | $204k–$4.5M |
|
Sandwater
VC Fund
|
1 | Norway, Germany, France | Series A, Seed | AgTech, Medical, Agriculture | $8.5M–$24M |
|
CBC Investment Group
VC Fund
|
1 | Sweden, Denmark, Germany | Seed, Series B | Software, Biotechnology, SaaS | |
|
Volvere plc
VC Fund
|
1 | Denmark | Seed | Medical, Health Care, Biotechnology | |
|
Peter Sandberg
Angel
|
1 | Denmark, Kenya, Estonia | Angel, Pre-Seed, Secondary Market | Internet, SaaS, FinTech | $150k–$212k |
|
North-East Healthcare Investment
VC Fund
|
1 | Denmark | Series A | Therapeutics, Biotechnology, Medical Device | |
|
Supernova Invest
VC Fund
|
1 | France, Switzerland, United States | Series A, Series B | Manufacturing, Health Care, Medical Device | $6.6M–$60M |
|
Lars Marcher
Angel
|
1 | Denmark | Series A | Consulting, Health Care, Medical Device | |
|
Norgine Ventures
VC Fund
|
1 | France, United Kingdom, Germany | Debt Financing, Series A | Health Care, Medical Device, Biotechnology | $2.6M–$16M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
| Access all 90 investors in Denmark Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Convertible Note, Pre-Seed, Debt Financing
- Geography: Denmark, Germany, Switzerland
Investor stats
- Total investments: 87
- Round size: Pre-Seed $516k–$5.2M; Debt Financing $533k–$1.4M; Convertible Note $500k–$1.5M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
- metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 134
- Round size: Seed $457k–$11M; Series A $5.9M–$43M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- MATR Foods — MATR Foods is a food-tech startup that provides fungi-based food ingredients offering dishes produced from fungi like mushrooms, vegetables, and fruits.
- VentriJect — VentriJect is a is a research facility that incorporates measuring cardiorespiratory fitness into everyone's checkup. They estimate respiratory fitness, which is a simple process. As a health indicator, people can increase their cardiorespiratory fitness. They have compiled a list of some of the other pertinent articles that relate to thesignificance of VO2-max measurement.
PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 143
- Round size: Seed $500k–$4.7M; Pre-Seed $88k–$2.5M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $42M in 2020
Portfolio highlights
- Viio — Oveo creates cloud-based software that enables any company in any industry to easily discover, manage, optimise and secure all SaaS usage from one platform.We believe employees should be able to enjoy work, be agile, move fast and in turn become more innovative on behalf of the companies they work for. In a subscribed economy a “SaaS-Poweredworkplace” is the enabling foundation to make that vision come true and at Oveo we proud to contribute by making SaaS usage more transparent, manageable and secure. Theircloud-based software enable companies to easily push this transformation and as SaaS adoption continues to skyrocket we will be right here with you - building the platform to manage and optimize the lifecycle of your SaaS applications.
- Woba — Woba is a SaaS aiming to support a stress-free work environment and minimise sick leave.
- eloomi — eloomi is an LMS platform for your workplace to train, retain & engage employees. Explore impactful learning & development today.
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 188
- Round size: Seed $515k–$5.2M; Series A $3.8M–$17M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $73M in 2021
Portfolio highlights
- abeo — One Organization with One Focus - To provide world-class technology-enabled revenue cycle management and related business solutions for facility-based physician specialties.
- Mofibo — Mofibo started in Copenhagen (2013) as one of the world’s first book subscription services. We are currently in three countries and will be expanding into more countries within the next 12 months. Our overall goal is to transform the way millions of people interact with books, through using a data-driven and customer centric approach tofundamentally change the reading experience crosses multiple countries.
- Asante Solutions — Asante Solutions was founded more than a decade ago in Denmark. While there, they developed close relationships with a select group of European-based venture capitalists. Backed with venture seed money, they began early stage development of an insulin delivery device that would ultimately become their first product - the Pearl Insulin Pump.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 196
- Round size: Seed $810k–$4.6M; Pre-Seed $412k–$1.2M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Merus Audio — Merus Audio is an audio company that develops switching audio amplifiers. The developed audio amplifiers consist a multilevel audio amplifier technology, which is a combination of a multilevel switching topology and a dynamic power management scheme to improve efficiency and compactness. The company's product eximo MA12040/12040P andMA12070/MA12070P are used for home theater systems, TVs, sound bars, stereo systems, mobile phones, and portable media players. They cut down power losses during operations.Merus Audio was found by Mikkel Hoyerby, and Hans Andersen in 2010; and is headquartered in Herlev, Denmark.
- First Agenda — FirstAgenda is designed to seamlessly facilitate administrative work from agenda sending to meeting preparation- and the holding of the meeting itself. With FirstAgenda, you can be confident that you have the most updated versions of the meeting material. Your material is always accessible for review - wherever you are.
- Blackwood Seven — Blackwood Seven is a media analytics platform which strives to increase the effect of company’s media spend using our predictive analytics framework built on machine learning and artificial intelligence. Using real-time modelling and advanced KPI prediction we are able to increase a company’s media ROI by up to 15-25%.
Backing founders with people, money and presence | People Ventures
Show more...Investment focus
- Industry: Software, Health Care, Internet of Things
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $1.1M–$19M; Pre-Seed $1.5M–$1.6M; Series A $6.3M–$21M
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- Alrik — Turn your logistics into a competitive advantage and take control of your emissions. We help building material suppliers revolutionize their workflows.
- Passendo — Passendo is the leading email ad server and platform for publishers and advertisers: unlock new revenue with powerful targeting and delivery.
- Pandektes — Legal Research, redefined.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 351
- Round size: Series A $9M–$125M; Series B $13M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- IVERIC bio — IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inheritedretinal diseases.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.
Show more...Investment focus
- Industry: Software, Health Care, Financial Services
- Stage:Series A, Seed
- Geography: United Kingdom, Denmark, Germany
Investor stats
- Total investments: 59
- Round size: Seed $2.6M–$5.9M; Series A $2M–$15M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Cercare Medical — Cercare Medical designs and develops a software tool for supporting acute stroke management, helping clinicians to evaluate the effect of a stroke. The software draws up the infarct-area within 30 seconds, locate perfusion area from images within 30 seconds and evaluate mismatch and generate a volume number of salvageable tissue. Cercare Medicalwas incorporated in 2013 under the name Combat Stroke and is based in Denmark.
- ATLANT 3D — Micro and nanodevices are built and tested within days instead of months or years.
- Formalize — A Whistleblower Software system made for accountants and lawyers that have clients, the whistleblower software system helps businesses implement a compliant solution that is both secure and transparent. their products are reporting links, case management, partner account they have designed a journey that makes feel safe about the process. AWS ishandling the physical security of the infrastructure, whistleblower software takes the shared responsibility of security between our cloud infrastructure and application seriously.
Chr. Augustinus Fabrikker operates as an investment management firm with a core focus on dedicated ownership of Danish businesses. Founded in 1750, Chr. Augustinus Fabrikker has a capital base of more than 30 billion, a significant player in the Danish business community. It is owned by the Augustinus Foundation, which is one of Denmark'slargest cultural foundations, and also makes significant contributions to research and social initiatives.
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Denmark
Investor stats
- Total investments: 18
- Round size: Series A $16M–$25M; Series B $21M–$76M; Series C $44M–$82M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Eupry — Be in full control of your temperature compliance at all times. Collect temperature monitoring, mapping, and calibration in one GxP-compliant solution.
- Podimo — Podimoa is an open podcast platform that offers a subscription service for creators. Founded in 2019, Podimo is a podcast and short-form audio platform which offers personalized recommendations to listeners, while offering creators a share of revenue via premium subscriptions. Co-founded by Morten Strunge, Nikolaj Koppel, Andreas Sachse, EvaLægdsgaard, and Sverre Dueholm, Podimo is hoping to capitalize on the rise in consumption in podcasts.
- Dawn Health — Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A
- Geography: Denmark, United Kingdom, Iceland
Investor stats
- Total investments: 29
- Round size: Seed $1.2M–$9.1M; Series A $5.6M–$22M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
- Onomondo — Onomondo is a global IoT network. Our IoT SIM and cloud platform future proof your devices with full data transparency, freedom to leave, and no third parties.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Denmark, Sweden, Finland
Investor stats
- Total investments: 20
- Round size: Seed $876k–$5.5M; Pre-Seed $917k–$1.7M; Venture - Series Unknown $1.1M–$7.5M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Skyfora — Skyfora delivers sub-kilometer insights, nowcasts, and probabilistic forecasts so your teams can plan with confidence, no matter the weather.
- P-Secure — P-Secure is a software company that provides a secure platform for businesses to conduct legally required background checks on employees, consultants, and suppliers. Its solution complies with regulations and serves industries including airports, energy, transport, telecom, research, and defense.
- Financial News Systems — Founded in 2024, FNS trains specialised AI models that extract news and data from financial press releases and regulatory filings, delivering it with “zero latency” to professional investors and analysts.
Stine Molgaard Sorensen is the Co-founder and COO of Radiobotics.
Show more...Investment focus
- Industry: Robotics, Software, Health Care
- Stage:Pre-Seed, Seed
- Geography: Denmark
Investor stats
- Total investments: 4
- Round size: Pre-Seed $174k–$1.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RiACT — Software for robots. Real-time development platform for creators and users of flexible robot applications.
- NordInsight — Instantly access MRI safety conditions, generate CPT-code ready reports, and standardize your workflow. NordInsight empowers radiology professionals with the tools they need to ensure safe, fast, and compliant MRI scans across all implants.
- Radiobotics — Our flagship product RBfracture is able to detect fractures in X-rays across the entire appendicular skeleton, and is MDR IIa certified. Also available: RBhip, RBknee and RBmarker
Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Farming
- Stage:Seed, Series A
- Geography: Denmark
Investor stats
- Total investments: 6
- Round size: Seed $4.3M–$8.8M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
- Enduro Genetics — Bioproduction can be difficult to scale to large cultivation volumes while keeping titers high. By applying game-changing synthetic biology technology, Enduro Genetics empowers our partner companies to maximize performance of all cells cultivated from their production strains.
- Lotus Microsystems — Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug andplay solutions enable our customers to innovate their electronics without worrying about power supply units.
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Pre-Seed, Seed
- Geography: Denmark, United States
Investor stats
- Total investments: 92
- Round size: Seed $66k–$1.3M; Grant $29k–$1.1M; Pre-Seed $64k–$1.6M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Prezio — Prezio is an electricity tariff data API for Europe. We aggregate, structure, and serve real-time and historical electricity pricing data - spot prices, retail tariffs, and grid fees - so energy applications don't have to build and maintain that data infrastructure themselves. Typical customers are developers and product teams building EVsmart charging, heat pump control, home batteries, and solar optimization tools - anything that needs to know what electricity actually costs, right now or over time, across European markets.
- PerPlant — PerPlant is an AI-sensor-based camera system that provides unparalleled, precise insights into their plants' health. They help farmers accelerate their transition into sustainable farming by democratizing access to artificial intelligence.
- SureShot — SureShot empowers you and your audience to become video co-creators. With our cutting-edge AI, capture, edit, and share electrifying videos that amplify the essence of every event.
Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 36
- Round size: Seed $960k–$8.5M; Pre-Seed $655k–$2.5M; Series A $5.2M–$14M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Delphinus Venture Capital is a venture investment management firm.
Show more...Investment focus
- Industry: Health Care, Food and Beverage, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Denmark
Investor stats
- Total investments: 11
- Round size: Seed $1.7M–$3.4M; Venture - Series Unknown $1.9M–$8.1M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Alcolase — Alcolase is a danish startup who develops the world's first enzyme system breaking down alcohol in the stomach (before it enters the blood).
- Decameal — Decameal envisions future food systems that are stable and sustainable, as well as healthy marine habitats.
- Ardos — Ardos is a developer of radiotherapy software designed to enhance cancer treatment.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 1792
- Round size: Seed $1.5M–$10M; Series A $5.5M–$37M; Series B $11M–$79M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Verishop — Shop designer clothing, shoes, bags and accessories from top Italian boutiques. Discover the latest luxury fashion at competitive prices with global shipping.
- Civis Analytics — Data solutions that deliver messages to your audiences and turn your data into successful campaigns. Make smarter, faster decisions that drive real results.
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Investo Capital is a Danish venture capital firm based in Aalborg. They invest in carefully selected Danish early-growth companies within tech business areas in the broad sense. The target group is innovative companies with proof of business, strategic thinking, and strong growth prospects in Denmark. Strategic corporate concepts and competentmanagement are essential features. The investment focus is Technology, IT, SAAS- and med-tech.
Show more...Investment focus
- Industry: Medical Device, Health Diagnostics, mHealth
- Stage:Seed
- Geography: Denmark
Investor stats
- Total investments: 6
- Round size: Seed $1.6M–$3.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VentriJect — VentriJect is a is a research facility that incorporates measuring cardiorespiratory fitness into everyone's checkup. They estimate respiratory fitness, which is a simple process. As a health indicator, people can increase their cardiorespiratory fitness. They have compiled a list of some of the other pertinent articles that relate to thesignificance of VO2-max measurement.
- Create it REAL — Tailored 3D printing solutions. We help you to get and control material, software, and 3D printers to start a 3D printed production unit.
- Brainreader — Brainreader was founded in 2011 as a spin-off from Aarhus University by a team of highly skilled and motivated individuals with complementary competencies dedicated to bringing our brain image analysis technology to the clinical market.Research done by The European Medicines Agency’s shows, that baseline measurement of low hippocampalvolume (i.e., atrophy) is a supportive indicator of evolution from cognitive impairment to Alzheimer´s disease and dementia. The Brainreader software is developed on the basis of such research.Brainreader wants to be a dominant player in the market for structural analysis of MRI’s. We want Neuroreader™ to be the routine tool of choice for physicians and MRI clinics all over the world when assessing structural MRI’s.Brainreader is currently bringing our new cutting-edge software tool, Neuroreader™, to the clinical market. It is our vision that Brainreader will deliver objective, precise, and personal analysis of brain scans. Ultimately increasing quality of life for the patient and significantly reducing disease-related costs for society.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 1821
- Round size: Seed $186k–$4.6M; Pre-Seed $108k–$755k; Series A $4.6M–$28M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Deja — Modern Rituals & Natural Products from the Ancient Science of Ayurveda
- Enoki Inc — Multiplayer-enabled tools for developers. Enoki has 18 repositories available. Follow their code on GitHub.
- Homethings — Single-use plastic is bonkers. Homethings makes cleaning products that make sense. No more shipping water in plastic bottles. We send non toxic cleaning tabs so that you can refill over and over again using your tap.
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more...Investment focus
- Industry: Information Technology, Medical, Software
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 163
- Round size: Seed $544k–$5M; Series A $1.2M–$10M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Fastree3D — Fastree3D imaging sensors help recognize and measure distance to fast moving objects in real-time, enabling driving assistance or autonomous navigation. Fastree3D SA is a fabless semiconductor company, spin-off from EPFL Lausanne, Switzerland founded in September 2013 (UID CHE-291.330.490). The company subsidiary Fastree3D B.V. performs researchwith TU-Delft, Netherlands (KvK 58866973).
- Spyra One — Single Shot Technology | Tactical display | Automatic Refill | Power Shot SpyraTwo - the world's strongest water gun! Start epic water battles with the only water gun in the world that features our patented Single-Shot-Technology, fully automatical pump, a hightech tactical display and the Power Shot for extra impact.
- DomoHealth — Join us in revolutionizing patient care using the power of AI-assisted digital health platform and safety solutions. Enhancing digital health with the best platform, application and devices for the direct benefits of patients and healthcare professionals.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Roland Berger is a Founder of Roland Berger, Munich and has been the Roland Berger GmbH's Honorary Chairman since 2010. Today, Roland Berger has grown to become one of the world's top five strategy consulting firms with 50 offices in 36 countries. The company has a workforce of 2,400 and advises leading international industrial andservice enterprises, as well as public institutions. From the company's foundation in 1967 until 2003, Roland was Chief Executive Officer of the firm, and until 2010 Chairman of the Supervisory Board. Prior to founding his strategy consultancy, Roland was employed as a consultant and ultimately partner at a leading American consulting firm based in Milan and Boston. Roland has been appointed to various expert commissions by several German state governments and the federal government. From 2007 to its dissolution in 2014, Roland was a Member of the High Level Group on Administrative Burdens under the leadership of former Bavarian State Premier Dr. Edmund Stoiber, appointed by the European Commission. Roland is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations, including Fresenius SE & Co. KGaA (Chairman of the Audit Committee), Bad Homburg; Prime Office REIT-AG, Munich (Chairman of the Supervisory Board); RCS Mediagroup S.p.A.(Vice-President), Milan, Italy. Roland also serves on several international advisory boards, including those of Deutsche Bank AG in Frankfurt, MillerBuckfire in New York and The Blackstone Group in New York. Since 1996 Roland has been a Lecturer and Visiting Professor and since 2000 Honorary Professor for Business Administration and Management Consulting at the Brandenburg Technical University in Cottbus. Furthermore, Roland was appointed a member of the Oxford Martin Commission for Future Generations in 2012. Since 2002, Roland has been on the Business Advisory Council of the State Premier of Saxony-Anhalt and was appointed to the Globalization Council Portugal by the Portuguese President Aníbal Cavaco Silva. Previously, German President Roman Herzog had appointed Roland to the President's Advisory Council for Innovation. Roland has also actively participated in over 20 federal government commissions under Helmut Kohl and Gerhard Schröder. Roland is a member of several supervisory boards and advisory councils of national and international companies, foundations and organizations and invests in many private and listed companies as well as startups. Roland was Honorary Consul General of the Republic of Finland in Bavaria and Thuringia from 1996 to 2015. Roland is Chairman of the Board of Trustees of the Roland Berger Foundation, which he set up personally with an endowment of EUR 50 million. The Roland Berger Foundation is dedicated to the global protection of human dignity and human rights. Each year it confers the Roland Berger Award for Human Dignity. The Foundation also helps gifted children and young people from underprivileged families across Germany and Italy to gain access to the best possible primary and secondary education. Outside work, Roland pursues his interest in modern art and owns a large collection of artworks, mainly by contemporary artists from Europe, the US, South America and China. Roland also loves classical music and supports the Mahler Chamber Orchestra and Bavarian State Opera, among others. Roland loves hiking and cross-country skiing, especially in the Swiss region of Engadin. Roland studied business administration in Munich and Hamburg. (MBA from the Ludwig-Maximilians-Universität, Munich).
Show more...Investment focus
- Industry: Financial Services, Information Services, Apps
- Stage:Series A, Series B
- Geography: Germany, Denmark, Switzerland
Investor stats
- Total investments: 8
- Round size: Series A $4.9M–$30M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- ALOHA — Healthy plant-based foods, snacks & meal replacements. Best organic plant based protein bars, shakes and powders. Nothing artificial. Welcome to ALOHA!
- Balance Re — Scaling the power of ALM
- Loanboox — Loanboox's success speaks for itself: Since the Go-live in September 2016, Loanboox dealt with a volume request over 61 billion Euros. More than 3000 cities and communities as well as institutional investors and banks are active on Loanboox. Loanboox is about to conquer the German, Austrian, French and Dutch market, too. And next step:Digitalisation of capital market.
The Midtjyske Ivaerksätterfond invests in entrepreneurial enterprises that are knowledge-intensive and innovative in order to produce growth, jobs, and value.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MedicQuant — MedicQuant is a medical equipment manufacturing company developing diagnostic kits for blood anticoagulant properties. The company's novel technology, chip, and instrument, Direct Oral Anticoagulants (DOACs), detect blood levels of the anticoagulants, directly from whole blood.
Steen Thygesen is the CEO of Audientes. He previously worked at Star as a Managing Director, Nordics. Steen Thygesen attended London Business School.
Show more...Investment focus
- Industry: Medical Device, Product Design
- Stage:Debt Financing
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Audientes — Audientes mission is to make quality hearing solutions accessible and affordable to everyone who needs them. In other words, to help hearing-impaired people hear and interact freely. We will achieve this by designing, developing and bringing to market innovative solutions for the millions who simply cannot afford a traditional hearing aid or do nothave access to an audiologist or hearing center. Audientes solutions address a large and growing global market.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 60
- Round size: Series A $5.5M–$43M; Series B $9.6M–$52M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $94M in 2019
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 89
- Round size: Seed $2M–$6.3M; Pre-Seed $573k–$2.4M; Series A $5M–$21M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
Sagitta Family Office is an entity that appears to manage various branches of investments and philanthropic activities. Sagitta Family Office encompasses like Sagitta Investments, Sagitta Ventures and Sagitta Charity Foundation.
Show more...Investment focus
- Industry: Biopharma, Health Care, Biotechnology
- Stage:Series A
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Eupry — Be in full control of your temperature compliance at all times. Collect temperature monitoring, mapping, and calibration in one GxP-compliant solution.
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Industry: Medical, Health Care, Finance
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $544k–$9.3M; Series A $1.2M–$7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
We are an independent, international, healthcare-focused asset management company. Led by entrepreneurial company builders and seasoned healthcare investors with experience across international markets, we invest in Healthcare growth capital and Healthcare public equities.
Show more...Investment focus
- Industry: Medical Device, Health Care, Biotechnology
- Stage:Series A, Series C
- Geography: France, Sweden, China
Investor stats
- Total investments: 12
- Round size: Series A $20M–$22M; Series C $55M–$55M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- Acandis — Acandis GmbH offers Engineering Stroke Solutions, Flow Diverter, Stent Retriever, Embolisation Devices, Acute Stroke Care, Thrombectomy, and PTA. They provide medical devices and products for the treatment of neurovascular diseases for patients. If anyone wants to contact them please contact them via phone call or email.
- Synovo Group — Synovo Group provides digital services and software publishing services for medical transport professionals. They are involved in hosting, infrastructure, cloud and telecom, supports companies in their digital transition. They offer hosting and outsourcing service that complies with the requirements of the HDS standard in terms of hosting healthdata. Their services include IT solutions, telecom, cloud services, sale of hardware and software, infrastructure hosting and outsourcing security consultancy, and data center.
Digital Leaders Ventures (DLV) is a European Venture Capital Fund based in Luxembourg. DLV is investing in tech companies disrupting industries on a global level. They focus on entrepreneurs from Europe who go global from day one, combining a scalable business model with high growth and large demand.
Show more...Investment focus
- Industry: SaaS, Mobile, Internet
- Stage:Seed, Angel, Series A
- Geography: United States, Denmark, France
Investor stats
- Total investments: 9
- Round size: Seed $800k–$3M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Enki — Enki is the most effective way to learn Looker, Tableau, SQL, Excel, and other data skills. Training fully customized by role and team. Use data in the highest impact way for your role.
- Revue — Revue is a developer of an editorial newsletter tool designed to build a direct relationship with the readers. Revue is for everyone that has passion through newsletters or a university graduate wanting to talk about their interests. more. Revue is based in The Netherlands and focuses on content curation.
- PayKey — The PayKey social banking and mobile P2P payment solution: A patent-pending mobile payment keyboard that seamlessly integrates with your banking application and lets users complete a transaction without leaving their social application.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 239
- Round size: Series A $3.1M–$27M; Series B $3.4M–$65M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ErVimmune — Our team is focused on bringing breakthrough immunotherapies in unmet medical needs for cancer patients. Check our work!
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- BAOUW / Outdoor Organic Nutrition — A raw, healthy, and natural diet made up of energy gels, energy bars, and energy fruit purees.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!KMD Venture operates in strategic growth segments and creates and manages user driven innovation, ideas generation, and incubation in close collaboration with users, customers, and business units. KMD Venture's purpose is to invest in opportunities that would not be picked up by KMD's existing business units, but may have great strategicand financial impact for KMD and to create and execute an external partnership setup to develop an entrepreneurial and innovative environment that can have a positive influence on KMD's innovation capability.KMD Venture only invests in startups and contribute with pre-seed or seed funding and the investment must have a strategic fit with KMD. KMD Venture A/S is owned by KMD A/S.
Show more...Investment focus
- Industry: Information Technology, Education, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diplomasafe — Issue digital diplomas, badges, and certificates at the click of a button.
- Egoo.Health — Egoo. Take action, own your health.
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Robotics
- Stage:Series B, Series C
- Geography: Switzerland, Germany, Belgium
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Fotokite — Specialized actively tethered UAS built for First Responders, providing immediate situational awareness of an emergency scene.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
- NIL Technology ApS — NIL Technology is an optical solutions company designing, developing, and manufacturing optical elements and components using high-precision nanoscale features
Sagitta Ventures invests in early-stage companies in the Nordics and provides long-term capital backing for well-managed businesses that are seeking minority investors without a defined exit horizon.
Show more...Investment focus
- Industry: Apps, Health Care, Mobile
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 7
- Round size: Series A $11M–$19M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Cerebriu — Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.Its software solution Cerebriu Apollo achieves the company's aim by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of thediagnostic process. The company covers findings of the brain, starting with brain MRI, including stroke, bleeds, and tumors, following MS, dementia, and TBI in brain CT.
- Howtorobot.com — HowToRobot is a global automation-marketplace platform that helps companies evaluate, source, and implement robotic and automation solutions. The platform enables users to describe the process they wish to automate, broadcast a “market request” to over 20,000 vetted suppliers, receive tailored quotes quickly, and compare options for budget, ROI,and risk.HowToRobot also offers independent advisory services—either via its own expert team or through its partner network—to guide companies from initial planning through implementation and help underserved firms navigate automation adoption. Additionally, the platform delivers educational content including articles on robot types, automation applications, and industry insights to help manufacturing or operations teams build internal knowledge.
- Donkey Republic — Donkey Republic is leading bike share service in Europe with footprint in more than 10 key cities in Europe. We operate our locations with partners, and use custom-branded bikes. Our software backbone is developed by us with unique features that ensure we respect public space with our hub-centric service model. At the same time, we maximizepredictability of bike availability and convenience. We pride ourselves in service innovation.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 230
- Lead/follow: no public data
Portfolio highlights
- Otoqi — Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for the automotive professionals.
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
- Orakl Oncology — Cultivated with love by the Orakl team.
ATP is a self-governing institution, established by the Folketing by law in 1964. ATP's Board of Directors consists of equal representatives of employers and employees and an independent chairman of the board. The ATP Group has approx. 3,000 employees. ATP is headquartered in Hillerød, customer service centers in Frederikshavn, Holstebro,Haderslev, Vordingborg, Lillerød and Hillerød, as well as offices in Copenhagen, Allerød and New York.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Software
- Stage:Series B
- Geography: Denmark
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- DSV — Connect your business with the world: Global transport and logistics - road, air, sea, rail freight and warehousing. Contact us today.
- MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
- Visiopharm — Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 87
- Round size: Seed $478k–$4.5M; Pre-Seed $204k–$2M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
- Retailgrid — Retailgrid is an AI-powered retail workspace that enables pricing, merchandising, and commercial teams to analyze data, run simulations, and make decisions in real time. Combining a flexible spreadsheet-like interface with AI agents, RetailGrid replaces fragmented tools and manual workflows with a single system for pricing optimization, promotionplanning, and assortment decisions. The platform connects to product, sales, and competitor data, automatically generates insights, and allows teams to test scenarios and deploy decisions at scale. RetailGrid is built for data-driven retailers looking to move faster and operate with the efficiency of top-tier consulting, without the cost or complexity.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.
Show more...Investment focus
- Industry: AgTech, Medical, Agriculture
- Stage:Series A, Seed
- Geography: Norway, Germany, France
Investor stats
- Total investments: 20
- Round size: Series A $8.5M–$24M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Nofence — Manage your livestock from anywhere with GPS collars and a simple app. Unlock more acres, cut fencing costs, and run your operation on your terms.
CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series B
- Geography: Sweden, Denmark, Germany
Investor stats
- Total investments: 12
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- GLX Analytix — GLX Analytix is a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
- Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
- Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
Volvere is an investment company that invests in or acquires companies which require growth capital. They may be profitable, under-performing or loss-making. We also acquire any company that is complementary to our existing portfolio or which is in a sector in which we have specialist knowledge. Our current trading businesses are organised intothree divisions: security solutions; food manufacturing; and automotive consultancy. Previous areas of investment have included online marketing, safety and risk consulting, transport planning and engineering, and testing and certification.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MedicQuant — MedicQuant is a medical equipment manufacturing company developing diagnostic kits for blood anticoagulant properties. The company's novel technology, chip, and instrument, Direct Oral Anticoagulants (DOACs), detect blood levels of the anticoagulants, directly from whole blood.
Peter Sandberg is a Co-Founder of Nordic Secondary Fund, and a venture partner at Startup Wise Guys. He has extensive experience as a Business Angel, Asset Management and Wealth Management
Show more...Investment focus
- Industry: Internet, SaaS, FinTech
- Stage:Angel, Pre-Seed, Secondary Market
- Geography: Denmark, Kenya, Estonia
Investor stats
- Total investments: 17
- Round size: Pre-Seed $150k–$212k
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- TRAPMINE — TRAPMINE Endpoint Protection Platform provides fool-proof defense against malware, exploit attempts, file-less malware, ransomware and other forms of targeted attacks.Unlike traditional detection-based approaches like legacy antivirus, TRAPMINE combines proven and innovative technologies such as deep learning, behavior monitoring, endpointdeception and anti-exploit techniques to block cyber threats dead in their tracks. TRAPMINE's easy-deploy and lightweight solution comes with a comfortable built-in security console, at a price/performance ratio unmatchable even by the biggest names in Palo Alto.Why TRAPMINE?Cyber criminals target companies of all sizes from every industry, seeking anything that might be of value. Antivirus and other traditional security solutions are no longer efficient to protect organizations from attacks by today’s modern cyber threat actors. That’s why we founded TRAPMINE. TRAPMINE is created to solve the malware problem for all organizations at a reasonable price.
- Colibo A/S — Use Colibo's intranet software as your enterprise collaboration platform to increase productivity, drive employee engagement and better internal communications.
- November First — November First - Betalingsplatform til alle virksomheder
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!North-East is an ambitious, global family office helping our families live with wealth in a meaningful way from our offices in Denmark and Singapore.
Show more...Investment focus
- Industry: Therapeutics, Biotechnology, Medical Device
- Stage:Series A
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Reapplix — Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.
we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical Device
- Stage:Series A, Series B
- Geography: France, Switzerland, United States
Investor stats
- Total investments: 100
- Round size: Series A $6.6M–$30M; Series B $7.7M–$60M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Heliup — Heliup is a company that creates and manufactures solar systems for huge building roofs for commercial and industrial buildings.
- Quobly — Quobly create and market a universal large-scale quantum computer, using tried-and-true semiconductor industry procedures.
- CrowdSec — CrowdSec is an open-source and collaborative security stack leveraging the crowd power. Analyze behaviors, respond to attacks & share signals across the community. Join the community and le's make the Internet safer, together.
Lars Marcher - Chairman of the Board @ System C Healthcare
Show more...Investment focus
- Industry: Consulting, Health Care, Medical Device
- Stage:Series A
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dawn Health — Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions.
Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Debt Financing, Series A
- Geography: France, United Kingdom, Germany
Investor stats
- Total investments: 20
- Round size: Debt Financing $2.6M–$16M
- Lead/follow: 70% lead, 30% follow
Portfolio highlights
- Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
- Alesi Surgical — Developer of Ultravision, the revolutionary system that clears surgical smoke from the visual field during laparoscopic surgery
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 319
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
- Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Medical Device Investor funding in Denmark at a glance
Stats across 124 deals from 90 investors.
Access all 90 investors in Denmark Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 90 investors investing in Denmark Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!